Le Lézard
Classified in: Health
Subject: POL

DNA Diagnostics Center® Ready to Provide Expedited Legally-Binding Immigration DNA Testing for Border Families


FAIRFIELD, Ohio, June 22, 2018 /PRNewswire/ -- DNA Diagnostics Center® (DDC® or the Company), the world's largest immigration DNA testing company, is ready to assist in reuniting families by providing expedited, legally-binding AABB (DEFINE AABB)-accredited immigration DNA tests, including sending trained professionals to all detention facilities, ensuring legal chain-of-custody protocols are followed.

DDC provides AABB-accredited legal DNA relationship testing, including maternity and paternity testing. DDC is ready to help at the border with expedited, legally-binding testing services.

The United States Citizenship and Immigration Services (USCIS) oversees the regulations pertaining to immigration DNA testing and only laboratories authorized by the AABB may be used. In the current situation, paternity-, maternity-, and siblingship DNA tests adhering to AABB standards are acceptable?ancestry DNA tests are not a legally binding solution. 

DDC processes over 1 million DNA samples each year in our accredited laboratory and has helped millions of families since 1995. The Company is highly-experienced and well versed with testing requirements in accordance with the United States Department of State Foreign Affairs Manual (FAM) for conducting genetic testing to verify and establish relationship for purposes of immigration.

In addition, the Company has a long history providing contract services to other governmental agencies, both state and county, for relationship chain-of-custody tests related to Title IV-D parentage cases for enforcing child support.  DDC currently has contractual partnerships with 22 state agencies, including Texas, plus the District of Columbia for family relationship testing services. 

Connie Hallquist, President and Chief Executive Officer of DNA Diagnostics Center®, states: "DDC is standing by and ready to assist our country with the current immigration challenge on our border and with parent/child reunification. As the world leader in immigration DNA testing, we have the accreditations, processes, systems, capacity, and experience to quickly provide U.S. government-sanctioned immigration DNA tests."

Once DNA samples are received at our Ohio-based laboratory from our professional collection team, results are ready in 1-2 days.  Since 1995, DDC employees have been dedicated to providing trusted answers for families and government institutions and are ready to assist our country now.

About DNA Diagnostics Center®:
DNA Diagnostics Center® (DDC®), founded over twenty years ago, is one of the world's largest private DNA testing companies with offices in Fairfield, Ohio (United States) and London, England (United Kingdom). DDC® offers DNA testing for paternity, immigration, forensics, genetic traits of animals, and ancestry.

DDC® is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA). DDC is also accredited by ACLASS to meet the international standards of ISO 17025 and the American Society of Crime Laboratory Directors / Laboratory Accreditation Board-International (ASCLD/LAB).  For more information visit www.dnacenter.com.

SOURCE DNA Diagnostics Center, Inc.


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
Closed System Transfer Devices Market in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...



News published on and distributed by: